Trial Profile
POST MARKETING SURVEILLANCE TO OBSERVE THE SAFETY AND EFFICACY OF DUAVIVE TAB 0.45MG/20MG
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Postmenopausal osteoporosis; Postmenopause; Vasomotor symptoms
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 01 Oct 2020 Status changed from active, no longer recruiting to completed.
- 06 Feb 2020 Planned End Date changed from 1 Dec 2019 to 30 Jun 2020.
- 06 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 30 Jun 2020.